/HYBT
HYBT Stock - Heyu Biological Technology Corporation
Healthcare|Medical - DevicesOTC
$0.35-41.67%
$0.25 (-41.67%) • Nov 17
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.39
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HYBT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.35 – $0.35
TARGET (TP)$0.40
STOP LOSS$0.32
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-17.89
52W High$3.40
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.87M | $2.68M | $78,953 | $96,478 | $222,701 |
| Gross Profit | $181,632 | $69,358 | $51,568 | $66,163 | $104,176 |
| Gross Margin | 6.3% | 2.6% | 65.3% | 68.6% | 46.8% |
| Operating Income | $-377,401 | $-470,000 | $-265,779 | $-162,836 | $-279,000 |
| Net Income | $-472,000 | $-379,000 | $-265,379 | $-163,020 | $-548,000 |
| Net Margin | -16.5% | -14.2% | -336.1% | -169.0% | -246.1% |
| EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.01 |
Company Overview
Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. It is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HYBTBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q3 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 14, 2025 | — | $0.00 | — | — |
Q1 2025 | Mar 28, 2025 | — | $-0.00 | — | — |
Q4 2024 | Nov 13, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 1, 2024 | — | $0.00 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 16, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 23, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 13, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 10, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 22, 2022 | — | $0.00 | — | — |
Q2 2022 | Jun 1, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 31, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 23, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 15, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 1, 2022 | — | $-0.00 | — | — |
Q4 2020 | Nov 16, 2020 | — | $-0.00 | — | — |
Q3 2020 | Aug 14, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about HYBT
What is HYBT's current stock price?
Heyu Biological Technology Corporation (HYBT) is currently trading at $0.35 per share. The stock has moved -41.67% today.
What is the analyst price target for HYBT?
No analyst price targets are currently available for this stock.
What sector is Heyu Biological Technology Corporation in?
Heyu Biological Technology Corporation operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is HYBT's market cap?
Heyu Biological Technology Corporation has a market capitalization of $0.36 billion, making it a small-cap company.
Does HYBT pay dividends?
No, Heyu Biological Technology Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBTMD
biote Corp.
$2.78
Mkt Cap: $0.1B
CSSPF
NIOX Group Plc
$0.92
Mkt Cap: $0.4B
DFHL
Dong Fang Hui Le Inc.
$4.00
Mkt Cap: $0.4B
GUERF
Guerbet S.A.
$22.25
Mkt Cap: $0.3B
HTLZF
Hamilton Thorne Ltd.
$1.59
Mkt Cap: $0.2B
ORRRY
Orpea S.A.
$0.30
Mkt Cap: $0.4B
PKBFF
PeakBirch Commerce Inc.
$0.00
Mkt Cap: $0.5B
SMDCF
SHL Telemedicine Ltd.
$17.15
Mkt Cap: $0.3B
SSII
SS Innovations International, Inc.
$5.72
Mkt Cap: $1.1B
TBGNF
Oxurion N.V.
$0.17
Mkt Cap: $0.4B
Explore stocks similar to HYBT for comparison